Snowball logo
logo
2M6_logo

Medtronic PLC

78.42-0.42  (0.53%)
Estimate
P/E
22.3
EPS
3.51
Beta
0.574
Growth
Revenue, YoY
7.08%
Net income, YoY
14.82%
FCF, YoY
-1.77%
Dividends
Dividend yield
3.16%
Annual payout
2.48
Next ex. div date
September 26, 26
Payout
75.8%
Div.growth, 5y
4.42%
Dividend growth streak
8 y
Div.rating
About the company
Ticker
2M6
ISIN
IE00BTN1Y115
Country
Ireland
Sector (GICS)
Healthcare
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring sys

Frequently asked questions

What sector does Medtronic PLC (2M6) operate in?

Medtronic PLC belongs to the Healthcare sector and operates in the Medical Devices industry.

What is Medtronic PLC (2M6) current stock price?

As of the latest data, Medtronic PLC stock price is €78.42, with a previous close of €78.84. Medtronic PLC lost -€0.42 in the last trading session, representing a -0.53% loss.

What is Medtronic PLC (2M6) current market capitalization?

Medtronic PLC market cap is approximately 100.31 billion.

What is Medtronic PLC (2M6) Earnings Per Share (EPS)?

The trailing EPS is €3.51.

What is Medtronic PLC (2M6) Price-to-Earnings (P/E) ratio?

Medtronic PLC current P/E ratio is 22.34.

Does Medtronic PLC (2M6) pay dividends?

Yes. Medtronic PLC pays quarterly dividends with an annualized yield of 3.16% and an estimated annual payout of €2.48 per share.

When is the next ex-dividend date for Medtronic PLC (2M6)?

The next ex-dividend date is scheduled for September 26, 2026.

When is Medtronic PLC (2M6) next earnings report?

Medtronic PLC is expected to release its next earnings report on July 31, 2026.

What is Medtronic PLC (2M6) beta (volatility) score?

Medtronic PLC has a beta of 0.574, indicating lower volatility than the overall market.